114
Views
8
CrossRef citations to date
0
Altmetric
Research Article

Cationic lipid emulsions as potential bioadhesive carriers for ophthalmic delivery of palmatine

, &
Pages 718-724 | Received 14 Jul 2016, Accepted 06 Oct 2016, Published online: 26 Oct 2016

References

  • Aoki S, Mizote H, Minamoto A, Suzuki M, Mishima HK, Tanaka H. Systemic FK506 improved tear secretion in dry eye associated with chronic graft versus host disease. Br J Ophthalmol, 2005;89:243–4.
  • Beilin M, Bar-Ilan A, Amselem S. Ocular retention time of submicron emulsion (SME) and the miotic response to pilocarpine delivered in SME. Invest Ophthalmol Vis Sci, 1995;36:S166.
  • Chetoni P, Monti D, Tampucci S, Matteoli B, Ceccherini-Nelli L, Subissi A, Burgalassi S. Liposomes as a potential ocular delivery system of distamycin A. Int J Pharm, 2015;492:120–6.
  • Dai Y, Zhou R, Liu L, Lu Y, Qi J, Wu W. Liposomes containing bile salts as novel ocular delivery systems for tacrolimus (FK506): in vitro characterisation and improved corneal permeation. Int J Nanomedicine, 2013;8:1921–33.
  • Freeberg FE, Nixon GA, Reer PJ, Weaver JE, Bruce RD, Griffith JF, Sanders LW. 3rd. Human and rabbit eye responses to chemical insult. Fundam Appl Toxicol, 1986;7:626–34.
  • Gallarate M, Chirio D, Bussano R, Peira E, Battaglia L, Baratta F, Trotta M. Development of O/W nanoemulsions for ophthalmic administration of timolol. Int J Pharm, 2013;440:126–34.
  • Gan L, Wang J, Jiang M, Bartlett H, Ouyang D, Eperjesi F, Liu J, Gan Y. Recent advances in topical ophthalmic drug delivery with lipid-based nanocarriers. Drug Discov Today, 2013;18:290–7.
  • Hartnett TE, O'Connor AJ, Ladewig K. Cubosomes and other potential ocular drug delivery vehicles for macromolecular therapeutics. Expert Opin Drug Deliv, 2015;12:1513–26.
  • Hegde RR, Bhattacharya SS, Verma A, Ghosh A. Physicochemical and pharmacological investigation of water/oil microemulsion of non-selective beta blocker for treatment of glaucoma. Curr Eye Res, 2014;39:155–63.
  • Jia F, Zou G, Fan J, Yuan Z. Identification of palmatine as an inhibitor of West Nile virus. Arch Virol, 2010;155:1325–9.
  • Jung J, Choi JS, Jeong CS. Inhibitory activities of palmatine from Coptis chinensis against Helicobactor pylori and gastric damage. Toxicol Res, 2014;30:45–8.
  • Katragadda S, Talluri RS, Mitra AK. Modulation of P-glycoprotein-mediated efflux by prodrug derivatization: an approach involving peptide transporter-mediated influx across rabbit cornea. J Ocul Pharmacol Ther, 2006;22:110–20.
  • Kaur H, Ahuja M, Kumar S, Dilbaghi N. Carboxymethyl tamarind kernel polysaccharide nanoparticles for ophthalmic drug delivery. Int J Biol Macromol, 2012;50:833–9.
  • Kim SY, Lee SJ, Lim SJ. Formulation and in vitro and in vivo evaluation of a cationic emulsion as a vehicle for improving adenoviral gene transfer. Int J Pharm, 2014;475:49–59.
  • Klang S, Abdulrazik M, Benita S. Influence of emulsion droplet surface charge on indomethacin ocular tissue distribution. Pharm Dev Technol, 2000;5:521–32.
  • Li M, Chen XM, Liu JJ, Wang DM, Gan L, Lv X, Qiao Y. Evaluation of cytotoxicity of some common ophthalmic drugs. Eur Rev Med Pharmacol Sci, 2015a;19:1945–50.
  • Li Q, Li Z, Zeng W, Ge S, Lu H, Wu C, Ge L, Liang D, Xu Y. Proniosome-derived niosomes for tacrolimus topical ocular delivery: In vitro cornea permeation, ocular irritation, and in vivo anti-allograft rejection. Eur J Pharm Sci, 2014;62:115–23.
  • Li W, Zhang T, Ye Y, Zhang X, Wu B. Enhanced bioavailability of tripterine through lipid nanoparticles using broccoli-derived lipids as a carrier material. Int J Pharm, 2015b;495:948–55.
  • Liu Y, Lin X, Tang X. Lipid emulsions as a potential delivery system for ocular use of azithromycin. Drug Dev Ind Pharm, 2009;35:887–96.
  • Nkwengoua ET, Ngantchou I, Nyasse B, Denier C, Blonski C, Schneider B. In vitro inhibitory effects of palmatine from Enantia chlorantha on Trypanosoma cruzi and Leishmania infantum. Nat Prod Res, 2009;23:1144–50.
  • Pescina S, Govoni P, Potenza A, Padula C, Santi P, Nicoli S. Development of a convenient ex vivo model for the study of the transcorneal permeation of drugs: histological and permeability evaluation. J Pharm Sci, 2015;104:63–71.
  • Puglia C, Offerta A, Carbone C, Bonina F, Pignatello R, Puglisi G. Lipid nanocarriers (LNC) and their applications in ocular drug delivery. Curr Med Chem, 2015;22:1589–602.
  • Royle L, Matthews E, Corfield A, Berry M, Rudd PM, Dwek RA, Carrington SD. Glycan structures of ocular surface mucins in man, rabbit and dog display species differences. Glycoconj J, 2008;25:763–73.
  • Saarinen-Savolainen P, Jarvinen T, Araki-Sasaki K, Watanabe H, Urtti A. Evaluation of cytotoxicity of various ophthalmic drugs, eye drop excipients and cyclodextrins in an immortalised human corneal epithelial cell line. Pharm Res, 1998;15:1275–80.
  • Sultana Y, Maurya DP, Iqbal Z, Aqil M. Nanotechnology in ocular delivery: current and future directions. Drugs Today (Barc), 2011;47:441–55.
  • Tamilvanan S, Benita S. The potential of lipid emulsion for ocular delivery of lipophilic drugs. Eur J Pharm Biopharm, 2004;58:357–68.
  • Ustundag-Okur N, Gokce EH, Egrilmez S, Ozer O, Ertan G. Novel ofloxacin-loaded microemulsion formulations for ocular delivery. J Ocul Pharmacol Ther, 2014;30:319–32.
  • Xiao CW, Ji QA, Wei Q, Liu Y, Bao GL. Antifungal activity of berberine hydrochloride and palmatine hydrochloride against Microsporum canis -induced dermatitis in rabbits and underlying mechanism. BMC Complement Altern Med, 2015;15:177.
  • Ying L, Tahara K, Takeuchi H. Drug delivery to the ocular posterior segment using lipid emulsion via eye drop administration: effect of emulsion formulations and surface modification. Int J Pharm, 2013;453:329–35.
  • Zhang X, Wu B. Submicron lipid emulsions: a versatile platform for drug delivery. Curr Drug Metab, 2015;16:211–20.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.